Indication
Advanced Breast Cancer
2 clinical trials
3 products
Clinical trial
Treatment of Canadian Men and Pre/Postmenopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted TherapyStatus: Completed, Estimated PCD: 2022-12-01
Product
Endocrine therapyClinical trial
Randomized Phase II Study of Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor (Palbociclib, Abemaciclib, or Ribociclib) in Patients With ER+/HER2- Advanced or Metastatic Breast Cancer With Prior Exposure to a CKD4/6 InhibitorStatus: Not yet recruiting, Estimated PCD: 2024-07-01
Product
Elacestrant